SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001804220-22-000004
Filing Date
2022-02-04
Accepted
2022-02-04 07:29:31
Documents
14
Period of Report
2022-02-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K regn-20220204.htm   iXBRL 8-K 32326
2 EXHIBIT 99.1 exhibit991q42021.htm EX-99.1 515594
6 image0a12.jpg GRAPHIC 7835
  Complete submission text file 0001804220-22-000004.txt   733871

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT regn-20220204.xsd EX-101.SCH 1911
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT regn-20220204_lab.xml EX-101.LAB 24229
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT regn-20220204_pre.xml EX-101.PRE 12602
8 EXTRACTED XBRL INSTANCE DOCUMENT regn-20220204_htm.xml XML 11550
Mailing Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591
Business Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 9148477000
REGENERON PHARMACEUTICALS, INC. (Filer) CIK: 0000872589 (see all company filings)

IRS No.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19034 | Film No.: 22590975
SIC: 2834 Pharmaceutical Preparations